Expand GLSI Menu
GLSI MENU

GLSI Latest Press Releases

-- July 22, 2026 --

Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom Globe Newswire 6:00 AM

-- July 20, 2026 --

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01 Globe Newswire 6:00 AM

-- July 16, 2026 --

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01 Globe Newswire 7:30 AM

-- July 9, 2026 --

Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01 Globe Newswire 6:00 AM

-- June 1, 2026 --

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026 Globe Newswire 8:15 AM
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing Globe Newswire 6:00 AM

-- May 22, 2026 --

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing Globe Newswire 4:30 PM

-- April 30, 2026 --

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing Globe Newswire 6:00 AM

-- April 23, 2026 --

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 Globe Newswire 6:00 AM

-- April 22, 2026 --

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing Globe Newswire 5:00 PM

-- April 20, 2026 --

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 Globe Newswire 6:00 AM

-- April 14, 2026 --

Greenwich LifeSciences Provides Update on Financing Strategy Globe Newswire 6:00 AM

-- April 7, 2026 --

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential Globe Newswire 6:00 AM

-- March 19, 2026 --

Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 Globe Newswire 6:00 AM

-- March 18, 2026 --

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting Globe Newswire 6:00 AM

-- March 17, 2026 --

Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- March 16, 2026 --

Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01 Globe Newswire 6:00 AM

-- March 3, 2026 --

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes